Trial site
HonorHealth Neurology
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease2 trials
- Dermatomyositis and polymyositis (myositis)2 trials
- Migraine2 trials
- ALS (motor neurone disease)1 trial
- Atrial fibrillation1 trial
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Coronary artery disease1 trial
- Mild cognitive impairment1 trial
- Multiple sclerosis1 trial
- Myasthenia gravis1 trial
- Stroke1 trial
- Phase
- Phase 38 trials
- Phase 25 trials
- Status
- Active, not recruiting5 trials
- Completed5 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Biogen4 trials
- Janssen Research & Development, LLC4 trials
- Ipsen2 trials
- Takeda2 trials
- Lakefront Biotherapeutics NV1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Site data: ClinicalTrials.govUpdated 13 Nov 2026